Dreamit Health is revamping its digital health accelerator with a new no-cash/no-equity option designed to draw later-stage companies and serial entrepreneurs who would not typically consider such a program. The company has also announced renewal of its partnerships with Independence Blue Cross (Independence) and Penn Medicine.

“In partnership with Independence Blue Cross and Penn Medicine, Dreamit has accelerated nearly 40 exceptional companies that are addressing the pain points we’re facing in health care today as well as anticipating the challenges of tomorrow,” Dreamit CEO Avi Savar said in a statement.

This year, Dreamit plans to spend $1 million investing in digital health companies. To date, it has invested more than $3.1 million in health care companies, which have gone to raise nearly $12.3 million in additional capital and many have secured pilot programs and contracts. The accelerator is currently accepting applications for its four-month program launching in March 2016.

Highlights from past Dreamit Health cohorts include 1DocWay, Aircare, Biomeme, Biobots and Towerview Health.